News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PositiveID (PSID) Partners With Diabetes Research Institute at the University of Miami and Schneider Children's Medical Center of Israel to Support Development of PositiveID's Diabetes Management Products



1/3/2012 9:32:17 AM

DELRAY BEACH, Fla., Jan. 3, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management and molecular diagnostic systems, announced today it has partnered with two leading diabetes research organizations, the Diabetes Research Institute ("DRI") at the University of Miami and Schneider Children's Medical Center of Israel ("Schneider Children's"), to support the continued development and study of PositiveID's diabetes management products.

Read at GlobeNewswire


comments powered by Disqus
   
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES